Mounjaro Weight Loss: Why Stopping Leads to Regain and Health Reversals - Study Insights

Описание: Mounjaro weight loss
Tirzepatide side effects
Weight regain after stopping
Obesity treatment study
Discover the latest findings on Mounjaro, a popular weight-loss jab containing tirzepatide. This video explores a new study showing that people who stop using Mounjaro not only regain weight but also lose other health benefits like reduced blood pressure and lower bad cholesterol levels.
Key points from the research:
Participants in the Surmount-4 trial experienced significant weight loss after 36 weeks on tirzepatide.
Those who switched to placebo regained up to 25% or more of their lost weight within a year.
Health improvements, including waist circumference, blood glucose, and cardiometabolic risks, reversed, especially with higher weight regain.
Experts emphasize the need for long-term weight management strategies beyond medication.
Additional studies link stopping weight-loss drugs to increased pregnancy risks for women.
Learn about the challenges of maintaining weight loss and the importance of lifestyle changes. Stay informed on obesity medications and their effects.